ORIC Pharmaceuticals Inc

ORICNASDAQ · USD
12.81USD-0.07 (-0.55%)
3210

ORIC Pharmaceuticals Inc (ORIC) Option Chain

As of September 17, 2026, ORIC Pharmaceuticals Inc is trading at $12.81, a -0.55% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 194.8%. IV Rank is 64%.

Read more

Tracking the ORIC option chain helps you see every strike and expiry on ORIC Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. ORIC Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ORIC options activity at a glance. Use our scanner to monitor the ORIC option chain in real time and filter for the ORIC options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ORIC stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ORIC option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ORIC stock options are being actively traded and where they are not.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations.

The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls ORIC Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ORIC options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ORIC stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile84.13% Elevated
  • Market cap (M$)1,335
  • 52 weeks high-13.73%
  • 52 weeks low78.15%
  • Analyst recommendationStrong Buy
    1.14
  • Target price$20.67
    61.36% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-12
  • P/E
  • Future P/E
  • EPS (ttm)-1.35
  • EPS growth next 5 years-4.89%

As of September 17, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
49.13001.341.811.005.3011.00-14.600.501.300.000.9010850.87
55.47001.690.810.104.9012.00-6.830.104.900.002.5001044.53
61.192102.050.000.104.0013.00+0.930.104.900.192.310238.81
66.27202.500.000.104.9014.00+8.701.054.901.191.790433.73
70.764011.430.000.102.7515.00+16.461.005.402.191.010129.24

As of September 17, 2026

Scan the full option chain in one place

Browse the full ORIC option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial